Venous

(Blood-Derived) Stem Cell Procedure

022416_TreatmentImages_Venous

Overview

For those looking for an alternative to our bone marrow derived treatment, they may undergo a venous stem cell treatment. This purely blood-derived treatment is less invasive compared to the bone marrow collection process. Venous stem cell treatment specializes in hematopoietic stem cells compared to both hemapoietic and mesenchymal stem cells found in bone marrow. In addition, follow-up treatments may need to be performed more often for optimal results.

Venous Stem Cell Procedure

Just like the bone marrow procedure, the venous stem cell procedure is performed in a clinical outpatient setting over the course of three days. After the Lung Institute’s medical staff has determined that a patient is a candidate for treatment, he or she will be asked to fill out all of the required paper work. A pulmonary function test will be performed, and the patient will go through a preparation process. Following the insertion of an IV, the autologous, hematopoietic stem cells are harvested, separated and immediately returned to the patient’s body intravenously where they can promote healing. This process is repeated on day two and day three of the patient’s treatment program. This minimally invasive procedure is less painful than the bone marrow procedure and has proven to be a viable option for many patients with chronic obstructive pulmonary disease (COPD). At the end of day three, the overseeing physician will do a thorough evaluation of the patient’s treatment and prep him or her for follow-up care.

Follow-Up Care

The patient will receive follow up care at the two-week, three-month and six-month mark following his or her treatment. The patient is encouraged to return for a follow-up appointment with his or her pulmonologist at the three-month mark.

If you would like to find out more about our available treatment options, please contact one of our patient care coordinators today at (800) 729-3065 to schedule a free consultation.


Related Posts

  • The Future of Regenerative MedicineThe Future of Regenerative Medicine is bright, and more promising all the time. Future breakthroughs in regenerative medicine promise the ability to regrow tissue to cure disease or repair damaged ... Read more
  • LI_BLOG_feb_11Venous or Bone Marrow The Lung Institute offers a bone marrow option for stem cell treatments. People with the debilitating symptoms of lung diseases like chronic obstructive pulmonary disease (COPD) and pulmonary ... Read more

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.